Identifying risk factors for L’Hermitte’s sign after IMRT for head and neck cancer

BACKGROUND: L’Hermitte’s sign (LS) after chemoradiotherapy for head and neck cancer appears related to higher spinal cord doses. IMRT plans limit spinal cord dose, but the incidence of LS remains high. METHODS: One hundred seventeen patients treated with TomoTherapy™ between 2008 and 2015 prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Laidley, Hannah M., Noble, David J., Barnett, Gill C., Forman, Julia R., Bates, Amy M., Benson, Richard J., Jefferies, Sarah J., Jena, Rajesh, Burnet, Neil G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936022/
https://www.ncbi.nlm.nih.gov/pubmed/29728105
http://dx.doi.org/10.1186/s13014-018-1015-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936022/
https://www.ncbi.nlm.nih.gov/pubmed/29728105
http://dx.doi.org/10.1186/s13014-018-1015-0

Ejemplares similares